Arkolith/Insider Trading/FMDT/Form 4

Bizily Scott

Chief Legal and HR Officer4D Molecular Therapeutics, Inc. (FMDT) · full profile →Form 4 · filed Jun 6, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$41K
Net Open-Market Flow
-$41K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2023Sell(S)2K$18.31$41K2K
Jun 1, 2023Option exercise(M)2K$6.49$12K4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 1, 2023Option exercise(M)2K—$018K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-23-000098) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML